WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology…
Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwindsPALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc.…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency…
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency…
LONDON, UK / ACCESSWIRE / May 9, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on…
LONDON, UK / ACCESSWIRE / May 9, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on…
Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…
Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…
Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after…